Author: Brittney Wheeler

Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor and vice chair of innovation and translation in WashU Medicine’s John F. Hardesty, MD, Department of Ophthalmology & Visual Sciences, has received the 2025 Retina Research Foundation’s Gertrude D. Pyron Award.

Ana Maria Arbeláez, MD, and Stephanie A. Fritz, MD, have been named co-vice chairs of clinical investigation in the Department of Pediatrics at WashU Medicine.

A new study from WashU Medicine researchers describes the structure of an important protein that unspools the DNA molecule so the DNA can be repaired. Interfering with the protein could prove useful in developing new therapeutics for tuberculosis or other diseases caused by organisms that rely on these proteins to repair their DNA.

Two recent studies from researchers at WashU Medicine reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection, putting them at risk of long-term health problems.

WashU Medicine researchers led by Siyuan Ding identified an immune-system protein in human cells that has the unusual capacity to respond to both DNA and RNA from pathogens, which may have implications for developing vaccines.

The Danforth Staff Council at WashU has added 10 new members and elected its executive officers for the academic year.

WashU Medicine faculty members received funding from the National Institutes of Health (NIH) to develop the Postbaccalaureate Research Education Program in Diabetes, Endocrinology and Metabolic Diseases, a two-year mentored research experience.

A specialized approach to treating childhood depression developed by WashU Medicine researchers leads to long-term remission and other benefits, according to a new study.

The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.

Fixing problems with cholesterol metabolism might help slow or prevent age-related macular degeneration, a leading cause of blindness in older adults, a new WashU Medicine study in mice has shown.